Endocrine Deep Dives

Endocrine Deep Dives

By Gurbir Gill, MDEducationCourses
Download on the App Store

Endocrine Deep Dives episodes

  • Vit D3 + K2?

    This episode explores the physiological synergy of combining vitamin D3 and vitamin K2 for optimal bone and cardiovascular health. We examine how vitamin D3 enhances intestinal calcium absorption, while vitamin K2 acts as a traffic director by activating osteocalcin and matrix Gla protein. This ensures that the newly absorbed calcium is directed into the bone matrix rather than being pathologically deposited in the arterial walls, providing a balanced approach to micronutrient supplementation in clinical practice.


    21 min
  • Thyrotoxic Periodic Paralysis

    This episode examines thyrotoxic periodic paralysis, a dangerous but reversible complication of hyperthyroidism characterized by acute muscle weakness and hypokalemia. We break down the underlying three-hit pathophysiology, where excess thyroid hormone upregulates the sodium-potassium pump, genetic mutations impair outward potassium channels, and an environmental trigger like insulin or epinephrine induces a massive intracellular potassium shift. Finally, we review acute management using nonselective beta-blockers and definitive therapies to restore euthyroidism.


    25 min
  • Wolff-Chaikoff and Jod-Basedow

    This episode explores the complex relationship between iodine and the thyroid gland, focusing on the Wolff-Chaikoff effect and the Jod-Basedow phenomenon. We break down the molecular mechanisms of iodine-induced thyroid suppression, the critical sodium-iodide symporter downregulation that allows normal tissue to escape prolonged hypothyroidism, and the triggers for iodine-induced thyrotoxicosis in autonomous glands. Finally, we review the management of modern triggers like contrast media, amiodarone, and therapeutic applications in thyroid storm.


    22 min
  • Marine-Lenhart Syndrome

    This episode explores Marine-Lenhart syndrome, a rare variant of thyrotoxicosis where Graves disease and autonomous thyroid nodules coexist within the same gland. We examine the dual mechanism of thyrotropin receptor activation, contrasting extrinsic antibody stimulation with permanent, somatic mutations. The discussion covers the clinical challenges this creates, including the classic scintigraphic unmasking of nodules, resistance to standard radioiodine therapy, and the compounding malignancy risks that make total thyroidectomy a preferred definitive management strategy.


    23 min
  • Spongiform Thyroid Nodules

    This episode explores spongiform thyroid nodules, a distinct sonographic pattern characterized by microcystic spaces that occupy more than half of the nodule volume. We break down the pathology of these colloid-filled hyperplastic follicles, which carry an exceptionally low malignancy risk of less than two percent. The discussion reviews classification across major guideline systems, conservative management thresholds, and why this highly reliable indicator of benign disease can independently rule out the need for fine-needle aspiration biopsy.


    20 min
  • Drug Effects on Deiodinases

    This episode examines how common medications alter thyroid hormone economy by targeting the iodothyronine deiodinase enzyme system. We contrast propylthiouracil, which selectively blocks type one deiodinase through a covalent mechanism, with amiodarone, which powerfully inhibits both type one and type two deiodinases to alter systemic feedback. Finally, we review the lipophilicity dependent effects of propranolol and the multi level impact of glucocorticoids, providing a rational framework for managing thyroid storm and interpreting complex laboratory profiles.


    20 min
  • Consumptive Hypothyroidism

    This episode examines consumptive hypothyroidism, a rare paraneoplastic syndrome driven by the accelerated degradation of thyroid hormones. We discuss how vascular and mesenchymal tumors, such as infantile hepatic hemangiomas and gastrointestinal stromal tumors, aberrantly overexpress the inactivating enzyme type three iodothyronine deiodinase. The discussion covers the classic biochemical profile of elevated thyroid stimulating hormone and markedly increased reverse triiodothyronine, alongside the aggressive, high-dose hormone replacement strategies and tumor-targeted interventions required to successfully restore systemic euthyroidism.


    22 min
  • NTI Syndrome

    This episode demystifies non-thyroidal illness syndrome, breaking down the dramatic shifts in thyroid hormone economy that occur during systemic illness. We discuss the acute phase, where suppressed type one deiodinase and upregulated type three deiodinase cause a rapid drop in triiodothyronine and a rise in reverse triiodothyronine. Finally, we examine how chronic illness triggers central hypothalamic-pituitary-thyroid axis suppression, keeping thyroid stimulating hormone paradoxically normal or low, and outline the distinct hormonal rebound seen during recovery.

    21 min
  • Graves vs Hashitoxicosis

    This episode explores the autoimmune thyroid disease spectrum, detailing the clinical overlap and physiological distinctions between Graves disease and Hashimoto thyroiditis. We contrast the active thyroid hormone overproduction driven by stimulating thyrotropin receptor antibodies in true hyperthyroidism with the transient, destructive hormone release seen in hashitoxicosis. The discussion reviews diagnostic strategies using antibody assays, radioactive iodine uptake scans, and triiodothyronine to thyroxine ratios to accurately differentiate these overlapping conditions and guide their appropriate clinical management.


    25 min
  • Nuclear Thyroid Imaging

    This episode evaluates the clinical utility of technetium-99m, iodine-123, and iodine-131 in thyroid imaging and therapy. We compare technetium-99m, trapped but not organified by the sodium-iodide symporter, with iodine-123, the preferred isotope for diagnostic uptake and high-resolution scanning. Finally, we look at iodine-131, which is reserved primarily for targeted thyroid ablation due to its high-energy beta emission, providing a clear framework for selecting the appropriate radiotracer based on diagnostic or therapeutic clinical goals.


    22 min

About Endocrine Deep Dives

From the publisher's feed

The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts.